All Title Author
Keywords Abstract

PLOS ONE  2012 

Polymorphisms of the DNA Methyltransferase 1 Associated with Reduced Risks of Helicobacter pylori Infection and Increased Risks of Gastric Atrophy

DOI: 10.1371/journal.pone.0046058

Full-Text   Cite this paper   Add to My Lib

Abstract:

Introduction DNA methyltransferase-1(DNMT1) is an important enzyme in determining genomic methylation patterns in mammalian cells. We investigated the associations between SNPs in the DNMT1 gene and risks of developing H. pylori seropositivity, gastric atrophy and gastric cancer in the Chinese population. Methods The study consisted of 447 patients with gastric cancer; 111 patients with gastric atrophy; and 961 healthy controls. Five SNPs, rs10420321, rs16999593, rs8101866, rs8111085 and rs2288349 of the DNMT1 gene were genotyped. Anti-H.pylori IgG was detected by ELISA. Gastric atrophy was screened by the level of serum pepsinogen Ιand II and then confirmed by endoscopy and histopatholgical examinations. Results The age- and sex-adjusted OR of H. pylori seropositivity was 0.67 (95%CI: 0.51–0.87) for rs8111085 TC/CC genotypes, significantly lower than the TT genotype in healthy controls. The adjusted OR of H.pylori seropositivity was 0.68 (95%CI: 0.52–0.89) for rs10420321 AG/GG genotypes. In addition, patients carrying rs2228349 AA genotype have a significantly increased risk for H.pylori seropositivity (OR = 1.67; 95%CI: 1.02–2.75). Further haplotype analyses also showed that the ATTTG and ATCTA are significantly associated with increased risks in H.pylori infection compared to the GTCCG haplotype (OR = 1.38, 95%CI: 1.08–1.77; OR = 1.40, 95% CI: 1.09–1.80). The adjusted ORs of gastric atrophy were 1.66 (95%CI: 1.06–2.61) for rs10420321 GG genotype, and 1.67 (95%CI 1.06–2.63, P = 0.03) for rs8111085 CC genotype, but no association was found between SNPs in the DNMT1 gene and risk of developing gastric cancer. Conclusions Individuals with rs10420321 GG and rs8111085 CC genotype of the DNMT1 gene were associated with reduced risks for H.pylori infection. On the other hand, higher risks of gastric atrophy were found in the carriers with these two genotypes compared to other genotypes. Our results suggested that SNPs of DNMT1 could be used as genotypic markers for predicting genetic susceptibilities to H.pylori infection and risks in gastric atrophy.

References

[1]  Hamiliton SA (2000) WHO classification of tumors. Lyon: IARC Press.
[2]  (2011) Yearbook of health in the people’s republic of China 2010: China Yearbook Press.
[3]  Lochhead P, El-Omar EM (2007) Helicobacter pylori infection and gastric cancer. Best Pract Res Clin Gastroenterol 21: 281–297.
[4]  Kabir S (2009) Effect of Helicobacter pylori eradication on incidence of gastric cancer in human and animal models: underlying biochemical and molecular events. Helicobacter 14: 159–171.
[5]  Amieva MR, El-Omar EM (2008) Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 134: 306–323.
[6]  Snaith A, El-Omar EM (2008) Helicobacter pylori: host genetics and disease outcomes. Expert Rev Gastroenterol Hepatol 2: 577–585.
[7]  Hishida A, Matsuo K, Goto Y, Hamajima N (2010) Genetic predisposition to Helicobacter pylori-induced gastric precancerous conditions. World J Gastrointest Oncol 2: 369–379.
[8]  Cedar H, Bergman Y (2012) Programming of DNA methylation patterns. Annu Rev Biochem 81: 97–117.
[9]  Maekita T, Nakazawa K, Mihara M, Nakajima T, Yanaoka K, et al. (2006) High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 12: 989–995.
[10]  Nakajima T, Yamashita S, Maekita T, Niwa T, Nakazawa K, et al. (2009) The presence of a methylation fingerprint of Helicobacter pylori infection in human gastric mucosae. Int J Cancer 124: 905–910.
[11]  Okano M, Xie S, Li E (1998) Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet 19: 219–220.
[12]  Kanai Y, Ushijima S, Kondo Y, Nakanishi Y, Hirohashi S (2001) DNA methyltransferase expression and DNA methylation of CPG islands and peri-centromeric satellite regions in human colorectal and stomach cancers. Int J Cancer 91: 205–212.
[13]  Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H, et al. (2001) Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis. Hepatology 33: 561–568.
[14]  Kanai Y, Ushijima S, Nakanishi Y, Sakamoto M, Hirohashi S (2003) Mutation of the DNA methyltransferase (DNMT) 1 gene in human colorectal cancers. Cancer Lett 192: 75–82.
[15]  Chun JY, Bae JS, Park TJ, Kim JY, Park BL, et al. (2009) Putative association of DNA methyltransferase 1 (DNMT1) polymorphisms with clearance of HBV infection. BMB Rep 42: 834–839.
[16]  Park BL, Kim LH, Shin HD, Park YW, Uhm WS, et al. (2004) Association analyses of DNA methyltransferase-1 (DNMT1) polymorphisms with systemic lupus erythematosus. J Hum Genet 49: 642–646.
[17]  Leng S, Stidley CA, Bernauer AM, Picchi MA, Sheng X, et al. (2008) Haplotypes of DNMT1 and DNMT3B are associated with mutagen sensitivity induced by benzo[a]pyrene diol epoxide among smokers. Carcinogenesis 29: 1380–1385.
[18]  Cao Q, Ran ZH, Xiao SD (2007) Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies. J Dig Dis 8: 15–22.
[19]  De La Vega FM (2007) Selecting single-nucleotide polymorphisms for association studies with SNPbrowser software. Methods Mol Biol 376: 177–193.
[20]  Lin DY, Zeng D, Millikan R (2005) Maximum likelihood estimation of haplotype effects and haplotype-environment interactions in association studies. Genet Epidemiol 29: 299–312.
[21]  Zeng D, Lin DY, Avery CL, North KE, Bray MS (2006) Efficient semiparametric estimation of haplotype-disease associations in case-cohort and nested case-control studies. Biostatistics 7: 486–502.
[22]  Bodger K, Crabtree JE (1998) Helicobacter pylori and gastric inflammation. Br Med Bull 54: 139–150.
[23]  D’Elios MM, Amedei A, Del Prete G (2003) Helicobacter pylori antigen-specific T-cell responses at gastric level in chronic gastritis, peptic ulcer, gastric cancer and low-grade mucosa-associated lymphoid tissue (MALT) lymphoma. Microbes Infect 5: 723–730.
[24]  Haeberle HA, Kubin M, Bamford KB, Garofalo R, Graham DY, et al. (1997) Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa. Infect Immun 65: 4229–4235.
[25]  Bergman M, Del Prete G, van Kooyk Y, Appelmelk B (2006) Helicobacter pylori phase variation, immune modulation and gastric autoimmunity. Nat Rev Microbiol 4: 151–159.
[26]  Flach CF, Ostberg AK, Nilsson AT, Malefyt Rde W, Raghavan S (2011) Proinflammatory cytokine gene expression in the stomach correlates with vaccine-induced protection against Helicobacter pylori infection in mice: an important role for interleukin-17 during the effector phase. Infect Immun 79: 879–886.
[27]  Smythies LE, Waites KB, Lindsey JR, Harris PR, Ghiara P, et al. (2000) Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice. J Immunol 165: 1022–1029.
[28]  Makar KW, Perez-Melgosa M, Shnyreva M, Weaver WM, Fitzpatrick DR, et al. (2003) Active recruitment of DNA methyltransferases regulates interleukin 4 in thymocytes and T cells. Nat Immunol 4: 1183–1190.
[29]  Penix LA, Sweetser MT, Weaver WM, Hoeffler JP, Kerppola TK, et al. (1996) The proximal regulatory element of the interferon-gamma promoter mediates selective expression in T cells. J Biol Chem 271: 31964–31972.
[30]  Bruniquel D, Schwartz RH (2003) Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat Immunol 4: 235–240.
[31]  Fitzpatrick DR, Shirley KM, McDonald LE, Bielefeldt-Ohmann H, Kay GF, et al. (1998) Distinct methylation of the interferon gamma (IFN-gamma) and interleukin 3 (IL-3) genes in newly activated primary CD8+ T lymphocytes: regional IFN-gamma promoter demethylation and mRNA expression are heritable in CD44(high)CD8+ T cells. J Exp Med 188: 103–117.
[32]  Makar KW, Wilson CB (2004) DNA methylation is a nonredundant repressor of the Th2 effector program. J Immunol 173: 4402–4406.
[33]  Svedruzic ZM (2011) Dnmt1 structure and function. Prog Mol Biol Transl Sci 101: 221–254.
[34]  Lee PH, Shatkay H (2009) An integrative scoring system for ranking SNPs by their potential deleterious effects. Bioinformatics 25: 1048–1055.
[35]  Etoh T, Kanai Y, Ushijima S, Nakagawa T, Nakanishi Y, et al. (2004) Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am J Pathol 164: 689–699.
[36]  Khatami F, Noorinayer B, Ghiasi S, Mohebi R, Hashemi M, et al. (2009) Lack of effects of single nucleotide polymorphisms of the DNA methyltransferase 1 gene on gastric cancer in Iranian patients: a case control study. Asian Pac J Cancer Prev 10: 1177–1182.
[37]  Khatami F, Noorinayer B, Mohebi SR, Ghiasi S, Mohebi R, et al. (2009) Effects of amino acid substitution polymorphisms of two DNA methyltransferases on susceptibility to sporadic colorectal cancer. Asian Pac J Cancer Prev 10: 1183–1188.
[38]  Xiang G, Zhenkun F, Shuang C, Jie Z, Hua Z, et al. (2010) Association of DNMT1 gene polymorphisms in exons with sporadic infiltrating ductal breast carcinoma among Chinese Han women in the Heilongjiang Province. Clin Breast Cancer 10: 373–377.
[39]  Ye C, Beeghly-Fadiel A, Lu W, Long J, Shu XO, et al. (2010) Two-stage case-control study of DNMT-1 and DNMT-3B gene variants and breast cancer risk. Breast Cancer Res Treat 121: 765–769.
[40]  Cebrian A, Pharoah PD, Ahmed S, Ropero S, Fraga MF, et al. (2006) Genetic variants in epigenetic genes and breast cancer risk. Carcinogenesis 27: 1661–1669.
[41]  Harlid S, Ivarsson MI, Butt S, Hussain S, Grzybowska E, et al. (2011) A candidate CpG SNP approach identifies a breast cancer associated ESR1-SNP. Int J Cancer 129: 1689–1698.
[42]  Kelemen LE, Sellers TA, Schildkraut JM, Cunningham JM, Vierkant RA, et al. (2008) Genetic variation in the one-carbon transfer pathway and ovarian cancer risk. Cancer Res 68: 2498–2506.

Full-Text

comments powered by Disqus